期刊文献+

冠心病候选基因β2肾上腺素能受体基因相关微小核糖核酸let-7i的实验研究 被引量:4

Preliminary Investigation of MicroRNAs Related to β_2 Adrenergic Receptor Gene in Rats
下载PDF
导出
摘要 目的:β2肾上腺素能受体(ADRB2)基因是冠心病最重要的候选基因之一,本研究探讨微小核糖核酸(miRNA)对ADRB2基因的调控及其在冠心病中的意义。方法:根据"种子区"原理预测对ADRB2具有调节作用的miRNA,按种系恒定性以及与冠心病的关系程度进一步筛选。对候选miRNA在大鼠心肌细胞H9c2(2-1)中进行增强和抑制处理,验证候选miRNA对ADRB2基因的调控。增强处理为加入相应miRNA的前体分子以提高其功能水平,抑制处理采用经化学修饰的变异体作为竞争性拮抗剂以抑制其活性水平。增强和抑制实验分别以miRNA自身序列随机化所产生的阴性分子作对照。前体或抑制剂经转染导入细胞,48 h后对ADRB2蛋白进行免疫印迹杂交分析。结果:研究结果表明,let-7i是冠心病背景下对ADRB2最具调控意义的miRNA之一。ANOVA统计分析显示,以let-7i增强剂处理心肌细胞48 h后使ADRB2蛋白水平降低了61.83%(P=0.0012),同时,以let-7i拮抗剂处理心肌细胞48 h导致ADRB2蛋白水平升高了48.49%(P=0.0071)。结论:let-7i对心肌细胞ADRB2水平具有显著的调节作用,并与之呈负相关,研究提示ADRB2的miRNA调控机制在冠心病病因学及治疗学中具有重要意义。 Objective: β2 adrenergic receptor(ADRB2)gene is one of the important coronary artery disease(CAD) candidate genes, our research investigated its related microRNAs for ADRB2 regulation with its significances for CAD occurrence in rats. Methods:The ADRB2 related microRNAs were predicted by "seed-region" principle, and further selected with their conser- vation properties and relevance to CAD. Rats' myocardial cell line H9c2 (2-1)was used for microRNAs enhancing and inhibiting tests. For enhancing experiment, microRNA precursor molecules were added to increase its function;and for inhibiting experiment, chemically modified microRNA molecules were sued as competitive antagonists to decrease its activity. The control materials were the corresponding scrambled negative molecules by randomized microRNA sequencing. The precursor and inhibitor were transfect- ed into H9c2(2-1 )cells and ADRB2 protein level was examined by immunoblotting analysis after 48 hours of treatment. Results:MicroRNA let-7i was one of the most prominent candidate regulators for CAD. ANOVA statistic analysis indicated that with 48 hour enhancing treatment of let-7i, the cellular protein level of ADRB2 decreased at 61.83%, P = 0. 0012; mean- while, with 48 hours antagonists treatment of let-7i, the cellular protein of ADRB2 increased at 48.49%, P = 0. 0071. Conclusion : MicroRNA let-7i could significantly and negatively regulate myocardial ADRB2 protein level in H9c2 (2-1)cells,the microRNA regulation for ADRB2 may play an important role for CAD occurrence in rats.
作者 郭威早 李琳
出处 《中国循环杂志》 CSCD 北大核心 2013年第1期63-66,共4页 Chinese Circulation Journal
关键词 Β2肾上腺素能受体 微小核糖核酸 基因 冠心病 β2 adrenergic receptor MicroRNA Gene Coronary artery disease
  • 相关文献

参考文献15

  • 1Piscione F,Iaccarino G,Galasso G. Effects of Ile164 polymorphism of beta2-adrenergic receptor gene on coronary artery disease[J].Journal of the American College of Cardiology,2008,(17):1381-1388.doi:10.1016/j.jacc.2008.07.034.
  • 2Cornett LE,Hiller FC,Jacobi SE. Identification of a glucocorticoid response element in the rat beta2-adrenergic receptor gene[J].Molecular Pharmacology,1998,(06):1016-1023.
  • 3Van Acker SA,Fluttert MF,Sibug RM. Intracerebroventricular administration of a glucocorticoid receptor antagonist enhances the cardiovascular responses to brief restraint stress[J].European Journal of Pharmacology,2001,(01):87-91.
  • 4Alevizaki M,Cimponeriu A,Lekakis J. High anticipatory stress plasma cortisol levels and sensitivity to glucocorticoids predict severity of coronary artery disease in subjects undergoing coronary angiography[J].Metabolism-Clinical and Experimental,2007,(02):222-226.
  • 5Hatfield SD,Shcherbata HR,Fischer KA. Stem cell division is regulated by the microRNA pathway[J].Nature,2005,(7044):974-978.
  • 6Krek A,Grun D,PoyMN. Combinatorial microRNA target predictions[J].Nature Genetics,2005,(05):495-500.doi:10.1038/ng1536.
  • 7郭威早,佟倩,曹立新,李琳.微小RNA对心肌细胞C反应蛋白功能水平的调节[J].中国实验诊断学,2010,14(12):1900-1902. 被引量:8
  • 8Friedman RC,Farh KK,Burge CB. Most mammalian mRNAs are conserved targets of microRNAs[J].Genome Research,2009,(01):92-105.doi:10.1101/gr.082701.108.
  • 9Satoh M,Tabuchi T,Minami Y. Expression of let-7i is associated with Toll-like receptor 4 signal in coronary artery disease:Effect of statins on let-7i and Toll-like receptor 4 signal[J].Immunobiology,2012,(05):533-539.
  • 10Madamanchi NR,Tchivilev I,Runge M. Genetic markers of oxidative stress and coronary atherosclerosis[J].Current Atherosclerosis Report,2006,(03):177-183.doi:10.1007/s11883-006-0071-3.

二级参考文献10

  • 1Bartel DP.MicroRNAs:genomics,biogenesis,mechanism,and function[J].Cell,2004,116 (2):281.
  • 2Chen K,Rajewsky N.Natural selection on human microRNA binding sites inferred from SNP data[J].Nat Genet,2006,38(12):1452.
  • 3Naga Prasad SV,Duan ZH,Gupta MK,et al.Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks[J].J Biol Chem,2009,284(40):27487.
  • 4Kilpatrick JM,Volanakis JE.Molecular genetics,structure,and function of C-reactive protein[J].Immunol Res,1991,10(1):43.
  • 5Lewis BP,Burge CB,Bartel DP.Conserved seed pairing,often flanked by adenosines,indicates that thousands of human genes are microRNA targets[J].Cell 2005,120(1):15.
  • 6Strum JC,Johnson JH,Ward J,et al.MicroRNA 132 regulates nutritional stress-induced chemokine production through repression of SirT1[J].Mol Endocrinol,2009,23(11):1876.
  • 7Kaptoge S,Di Angelantonio E,Lowe G,et al.C-reactive protein concentration and risk of coronary heart disease,stroke,and mortality:an individual participant meta-analysis[J].Lancet,375(9709):132.
  • 8Gemes K,Ahnve S,Janszky I.Inflammation a possible link between economical stress and coronary heart disease[J].Eur J Epidemiol,2008,23(2):95.
  • 9Yarnell J.Stress at work-an independent risk factor for coronary heart disease?[J].Eur Heart J,2008,29(5):579.
  • 10Qi X,Li S,Li J.The prognostic value of IL-8 for cardiac events and restenosis in patients with coronary heart diseases after percutaneous coronary intervention[J].Jpn Heart J,2003,44(5):623.

共引文献7

同被引文献44

  • 1尚明美,刘秀文,汤仲明,陈惠鹏.反义寡核苷酸的药代动力学研究进展[J].国外医学(药学分册),2004,31(4):240-245. 被引量:2
  • 2Stenvang J, Petri A. Lindow M. et al. Inhibition of mieroRNA function by antimiR oligomteleotides. Silenee, 2012.3: 1.
  • 3Bernardp BC. Gao XM, Winbanks CE, el al. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart fimction. Pric Natl Acad Sci USA. 2012, 109: 17615-17620.
  • 4Narolska NA, Eiras S. Van Loon RB. el al. Myosin heavy chain composition and the economy of contraction in healthy and diseased human myoeardium. J Muscle Res Cell Motil, 2005, 26: 39-48.
  • 5Lowes BD, C, ilherl EM. Abraham WT, et al. Myo,-ardial gene expressiCul in dilated cardiomyopathy treated wilh β -blocking agents. N Engl J Med, 2002, 346: 1357-1365.
  • 6Small EM, Olsnn EN. Pervasive roles of microRNAs in eardiovaseular biology. Nature. 2011. 469: 336-342.
  • 7Bernardo BC, Charchar FJ, Lin RCY, et al. A microRNA guide for clinicians and basic scientists: Background and experimental techniques. Hearl Lung Cite, 2012.21: 131-142.
  • 8Cubbon RM, Gale CP, Kearney LC, et al. Changing characteristics and mode of death associated with chronic heart failure caused by left ventrieular systolic dysfunction: a study across therapeutic eras. Circ Heart Fail, 2011, 4: 396-403.
  • 9MeMurray JJV. Systolic heat1 failure. N Engl J Med, 2010. 362: 228-238.
  • 10Cheng Y. Ji R, Yue J, et al. MicroRNAs are aberranlly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?. Am J Pathol, 2007, 170: 1831-1840.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部